Preterm Birth Prevention and Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Progesterone Therapy,Corticosteroid Therapy,Tocolytics Therapy,Antihypertensive Therapy,Magnesium Sulfate Therapy,Other), By Application (Hospital,Drugs Stores,Other), Regional Insights and Forecast to 2035

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Progesterone Therapy
1.2.3 Corticosteroid Therapy
1.2.4 Tocolytics Therapy
1.2.5 Antihypertensive Therapy
1.2.6 Magnesium Sulfate Therapy
1.2.7 Other
1.3 Market by Application
1.3.1 Global Preterm Birth Prevention and Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preterm Birth Prevention and Treatment Market Perspective (2018-2029)
2.2 Preterm Birth Prevention and Treatment Growth Trends by Region
2.2.1 Global Preterm Birth Prevention and Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Preterm Birth Prevention and Treatment Historic Market Size by Region (2018-2023)
2.2.3 Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2024-2029)
2.3 Preterm Birth Prevention and Treatment Market Dynamics
2.3.1 Preterm Birth Prevention and Treatment Industry Trends
2.3.2 Preterm Birth Prevention and Treatment Market Drivers
2.3.3 Preterm Birth Prevention and Treatment Market Challenges
2.3.4 Preterm Birth Prevention and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue
3.1.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue (2018-2023)
3.1.2 Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Preterm Birth Prevention and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preterm Birth Prevention and Treatment Revenue
3.4 Global Preterm Birth Prevention and Treatment Market Concentration Ratio
3.4.1 Global Preterm Birth Prevention and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preterm Birth Prevention and Treatment Revenue in 2022
3.5 Preterm Birth Prevention and Treatment Key Players Head office and Area Served
3.6 Key Players Preterm Birth Prevention and Treatment Product Solution and Service
3.7 Date of Enter into Preterm Birth Prevention and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preterm Birth Prevention and Treatment Breakdown Data by Type
4.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Type (2018-2023)
4.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2024-2029)
5 Preterm Birth Prevention and Treatment Breakdown Data by Application
5.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Application (2018-2023)
5.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Preterm Birth Prevention and Treatment Market Size (2018-2029)
6.2 North America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
6.4 North America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preterm Birth Prevention and Treatment Market Size (2018-2029)
7.2 Europe Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
7.4 Europe Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preterm Birth Prevention and Treatment Market Size (2018-2029)
8.2 Asia-Pacific Preterm Birth Prevention and Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preterm Birth Prevention and Treatment Market Size (2018-2029)
9.2 Latin America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
9.4 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preterm Birth Prevention and Treatment Market Size (2018-2029)
10.2 Middle East & Africa Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Detail
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.1.5 AMAG Pharmaceuticals Recent Development
11.2 Ferring Pharmaceutical
11.2.1 Ferring Pharmaceutical Company Detail
11.2.2 Ferring Pharmaceutical Business Overview
11.2.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Introduction
11.2.4 Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.2.5 Ferring Pharmaceutical Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Preterm Birth Prevention and Treatment Introduction
11.3.4 Teva Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.3.5 Teva Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Preterm Birth Prevention and Treatment Introduction
11.4.4 Allergan Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.4.5 Allergan Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Detail
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Preterm Birth Prevention and Treatment Introduction
11.5.4 AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.5.5 AbbVie Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Detail
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Introduction
11.6.4 Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.6.5 Aurobindo Pharma Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Preterm Birth Prevention and Treatment Introduction
11.7.4 Bayer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.7.5 Bayer Recent Development
11.8 Viatris
11.8.1 Viatris Company Detail
11.8.2 Viatris Business Overview
11.8.3 Viatris Preterm Birth Prevention and Treatment Introduction
11.8.4 Viatris Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.8.5 Viatris Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Preterm Birth Prevention and Treatment Introduction
11.9.4 Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Detail
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Preterm Birth Prevention and Treatment Introduction
11.10.4 Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.10.5 Merck & Co Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Preterm Birth Prevention and Treatment Introduction
11.11.4 Novartis Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Preterm Birth Prevention and Treatment Introduction
11.12.4 Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details